Collegium Pharmaceutical, Inc. COLL Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $289.56M+14.8% | $252.16M+68.0% | $150.1M+27.9% | $117.35M+0.2% | $117.09M+21.2% | ||
| $157.34M+1.2% | $155.43M+14.5% | $135.77M+29.5% | $104.81M+3.2% | $101.58M+10.2% | ||
| $228.76M+8.2% | $211.33M-9.7% | $233.95M+9.8% | $213.02M-6.9% | $228.71M+0.1% | ||
| $9.71M-30.7% | $14.01M-63.2% | $38.05M-0.3% | $38.15M+2.5% | $37.22M+4.7% | ||
| $745.67M+7.8% | $691.41M+12.6% | $613.87M+11.8% | $549.21M+4.1% | $527.55M+9.4% | ||
| $11.66M-2.9% | $12.01M-1.9% | $12.25M-5.1% | $12.9M-6.8% | $13.85M-3.3% | ||
| $145.93M0.0% | $145.93M0.0% | $145.93M-1.4% | $147.94M-1.9% | $150.76M-7.1% | ||
| $614.04M-8.3% | $669.51M-7.7% | $724.98M-7.1% | $780.46M-6.6% | $835.93M-6.2% | ||
| $1.65B-0.3% | $1.66B+3.1% | $1.61B+0.9% | $1.59B-2.4% | $1.63B-1.9% | ||
| $6.83M-35.9% | $10.66M+39.4% | $7.65M-29.8% | $10.89M-39.0% | $17.85M+354% | ||
| —— | —— | —— | —— | —— | ||
| $434.97M-1.1% | $440.03M-2.8% | $452.93M-2.5% | $464.61M-4.5% | $486.71M-4.5% | ||
| $1.34B-1.2% | $1.36B+1.7% | $1.33B-2.1% | $1.36B-2.6% | $1.4B-2.6% | ||
| 100M0.0% | 100M+243,802% | 41K+2.5% | 40K0.0% | 40K0.0% | ||
| -$86.63M+14.3% | -$101.13M+14.4% | -$118.09M+21.1% | -$149.6M+7.4% | -$161.58M+1.5% | ||
| $312.42M+3.6% | $301.68M+9.8% | $274.81M+18.3% | $232.21M-1.0% | $234.43M+2.4% | ||
| $1.65B-0.3% | $1.66B+3.1% | $1.61B+0.9% | $1.59B-2.4% | $1.63B-1.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Collegium Pharmaceutical, Inc.'s total assets?
- Collegium Pharmaceutical, Inc. (COLL) holds $1.7B in total assets, up 1.3% year over year.
- How much debt does Collegium Pharmaceutical, Inc. have?
- Collegium Pharmaceutical, Inc. carries $5.2M in total debt against $312.4M of shareholders' equity, a debt-to-equity ratio of 0.02.
- How much cash does Collegium Pharmaceutical, Inc. have?
- Collegium Pharmaceutical, Inc. holds $289.6M in cash and equivalents.
- Can Collegium Pharmaceutical, Inc. cover its short-term obligations?
- Its current ratio is 1.71 — current assets exceed current liabilities.
- Where does Collegium Pharmaceutical, Inc.'s balance sheet data come from?
- Every line is extracted from Collegium Pharmaceutical, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
